IRIS Accounts Production v24.2.0.383 06844311 director 28.3.23 27.3.24 27.3.24 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068443112023-03-27068443112024-03-27068443112023-03-282024-03-27068443112022-03-27068443112022-03-282023-03-27068443112023-03-2706844311ns14:PoundSterling2023-03-282024-03-2706844311ns10:Director12023-03-282024-03-2706844311ns10:PrivateLimitedCompanyLtd2023-03-282024-03-2706844311ns10:SmallEntities2023-03-282024-03-2706844311ns10:AuditExempt-NoAccountantsReport2023-03-282024-03-2706844311ns10:SmallCompaniesRegimeForDirectorsReport2023-03-282024-03-2706844311ns10:SmallCompaniesRegimeForAccounts2023-03-282024-03-2706844311ns10:FullAccounts2023-03-282024-03-270684431112023-03-282024-03-2706844311ns10:OrdinaryShareClass12023-03-282024-03-2706844311ns10:RegisteredOffice2023-03-282024-03-2706844311ns5:CurrentFinancialInstruments2024-03-2706844311ns5:CurrentFinancialInstruments2023-03-2706844311ns5:Non-currentFinancialInstruments2024-03-2706844311ns5:Non-currentFinancialInstruments2023-03-2706844311ns5:ShareCapital2024-03-2706844311ns5:ShareCapital2023-03-2706844311ns5:RetainedEarningsAccumulatedLosses2024-03-2706844311ns5:RetainedEarningsAccumulatedLosses2023-03-2706844311ns5:NetGoodwill2023-03-282024-03-2706844311ns5:IntangibleAssetsOtherThanGoodwill2023-03-282024-03-2706844311ns5:LeaseholdImprovements2023-03-282024-03-2706844311ns5:PlantMachinery2023-03-282024-03-2706844311ns5:FurnitureFittings2023-03-282024-03-2706844311ns5:MotorVehicles2023-03-282024-03-2706844311ns5:NetGoodwill2023-03-2706844311ns5:NetGoodwill2024-03-2706844311ns5:NetGoodwill2023-03-2706844311ns5:LeaseholdImprovements2023-03-2706844311ns5:PlantMachinery2023-03-2706844311ns5:FurnitureFittings2023-03-2706844311ns5:MotorVehicles2023-03-2706844311ns5:LeaseholdImprovements2024-03-2706844311ns5:PlantMachinery2024-03-2706844311ns5:FurnitureFittings2024-03-2706844311ns5:MotorVehicles2024-03-2706844311ns5:LeaseholdImprovements2023-03-2706844311ns5:PlantMachinery2023-03-2706844311ns5:FurnitureFittings2023-03-2706844311ns5:MotorVehicles2023-03-2706844311ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-2706844311ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-2706844311ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-2706844311ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-2706844311ns10:OrdinaryShareClass12024-03-27068443111ns10:Director12023-03-27068443111ns10:Director12022-03-27068443111ns10:Director12023-03-282024-03-27068443111ns10:Director12022-03-282023-03-27068443111ns10:Director12024-03-27068443111ns10:Director12023-03-27
REGISTERED NUMBER: 06844311















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 27 MARCH 2024

FOR

BRIGHTON IMPLANT CLINIC LTD

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BRIGHTON IMPLANT CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 27 MARCH 2024







DIRECTOR: B M Pedra Silva





REGISTERED OFFICE: 12 Church Road
Hove
East Sussex
BN3 2FL





REGISTERED NUMBER: 06844311





ACCOUNTANTS: Galloways Accounting (Hove) Limited
The Old Casino
28 Fourth Avenue
Hove
East Sussex
BN3 2PJ

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

BALANCE SHEET
27 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 3 - -
Tangible assets 4 633,120 697,792
633,120 697,792

CURRENT ASSETS
Stocks 5 40,000 40,000
Debtors 6 1,368,960 1,180,145
Cash at bank and in hand 31,150 48,110
1,440,110 1,268,255
CREDITORS
Amounts falling due within one year 7 1,092,216 1,297,687
NET CURRENT ASSETS/(LIABILITIES) 347,894 (29,432 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

981,014

668,360

CREDITORS
Amounts falling due after more than one
year

8

653,965

804,095
NET ASSETS/(LIABILITIES) 327,049 (135,735 )

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 327,047 (135,737 )
SHAREHOLDERS' FUNDS 327,049 (135,735 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 27 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 27 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 June 2024 and were signed by:





B M Pedra Silva - Director


BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 MARCH 2024

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

This is the first year in which the financial statements have been prepared under FRS 102. Any changes in accounting policy have been applied from the first day of the previous period. Equity has been reconciled to the previously stated amounts for the opening and closing position of the comparative period.

Turnover
Turnover represents sales of services and is recognised at the point the customer is entitled to consideration.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 7% on cost
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on cost
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 48 (2023 - 48 ) .

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 27 MARCH 2024

3. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 28 March 2023
and 27 March 2024 3,700,000
AMORTISATION
At 28 March 2023
and 27 March 2024 3,700,000
NET BOOK VALUE
At 27 March 2024 -
At 27 March 2023 -

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 28 March 2023 1,114,877 1,018,964 1,737 58,842 2,194,420
Additions - 63,374 19,741 - 83,115
At 27 March 2024 1,114,877 1,082,338 21,478 58,842 2,277,535
DEPRECIATION
At 28 March 2023 667,215 797,560 367 31,486 1,496,628
Charge for year 78,048 59,974 2,926 6,839 147,787
At 27 March 2024 745,263 857,534 3,293 38,325 1,644,415
NET BOOK VALUE
At 27 March 2024 369,614 224,804 18,185 20,517 633,120
At 27 March 2023 447,662 221,404 1,370 27,356 697,792

5. STOCKS
2024 2023
£    £   
Stocks 40,000 40,000

6. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 129,094 85,657
Amounts owed by group undertakings - 22,483
Other debtors 29,916 38,180
Tax 180,831 135,430
Prepayments and accrued income 104,590 89,047
444,431 370,797

Amounts falling due after more than one year:
Directors' loan accounts 924,529 809,348

Aggregate amounts 1,368,960 1,180,145

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 27 MARCH 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 253,246 231,019
Hire purchase contracts 33,921 14,048
Trade creditors 573,289 600,775
Tax 52,948 135,430
Social security and other taxes 20,405 20,944
Other creditors 147,763 232,020
Accrued expenses 10,644 63,451
1,092,216 1,297,687

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans - 1-5 years 607,346 761,548
Hire purchase contracts 46,619 42,547
653,965 804,095

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 27 March 2024 and 27 March 2023:

2024 2023
£    £   
B M Pedra Silva
Balance outstanding at start of year 809,348 372,950
Amounts advanced 396,339 615,873
Amounts repaid (281,158 ) (179,475 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 924,529 809,348

This balance represented the maximum amount outstanding during the year. Interest is charged on any overdrawn amounts at the beneficial loan interest rate.

11. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling parties are Mr B M Silva and Mrs M A J Silva by virtue of their combined 100% shareholding in the company.